Andra AP fonden Acquires 43,960 Shares of CME Group Inc. $CME

Andra AP fonden grew its holdings in shares of CME Group Inc. (NASDAQ:CME) by 91.5% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 91,990 shares of the financial services provider’s stock after buying an additional 43,960 shares during the quarter. Andra AP fonden’s holdings in CME Group were worth $20,314,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently made changes to their positions in CME. Wellington Altus USA Inc. bought a new stake in CME Group in the second quarter worth $49,000. Anchor Investment Management LLC raised its stake in shares of CME Group by 113.0% in the second quarter. Anchor Investment Management LLC now owns 805 shares of the financial services provider’s stock valued at $178,000 after acquiring an additional 427 shares during the period. Keystone Financial Planning Inc. raised its stake in shares of CME Group by 35.0% in the second quarter. Keystone Financial Planning Inc. now owns 43,265 shares of the financial services provider’s stock valued at $9,554,000 after acquiring an additional 11,228 shares during the period. Tidal Investments LLC lifted its holdings in shares of CME Group by 1.2% in the 2nd quarter. Tidal Investments LLC now owns 161,957 shares of the financial services provider’s stock worth $35,765,000 after acquiring an additional 1,851 shares during the last quarter. Finally, Van Hulzen Asset Management LLC lifted its holdings in shares of CME Group by 10.9% in the 2nd quarter. Van Hulzen Asset Management LLC now owns 31,062 shares of the financial services provider’s stock worth $6,860,000 after acquiring an additional 3,041 shares during the last quarter. Institutional investors own 87.75% of the company’s stock.

Analysts Set New Price Targets

Several brokerages recently commented on CME. TD Cowen reiterated a “buy” rating and set a $292.00 price target on shares of CME Group in a report on Thursday, September 3rd. Keefe, Bruyette & Woods upgraded CME Group from a “market perform” rating to an “outperform” rating and set a $305.00 target price for the company in a research report on Thursday, June 18th. Erste Group Bank cut CME Group from a “buy” rating to a “hold” rating in a research note on Friday, June 5th. JPMorgan Chase & Co. increased their price target on CME Group from $249.00 to $250.00 and gave the stock an “underweight” rating in a report on Thursday, July 23rd. Finally, Wall Street Zen upgraded CME Group from a “strong sell” rating to a “sell” rating in a report on Saturday, August 29th. Nine research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have given a Sell rating to the stock. Based on data from MarketBeat, the company has an average rating of “Hold” and an average price target of $289.75.

CME Group Trading Down 2.2%

CME traded down $6.18 on Tuesday, reaching $269.35. 573,253 shares of the company traded hands, compared to its average volume of 2,575,977. The company has a market cap of $96.85 billion, a P/E ratio of 22.85, a price-to-earnings-growth ratio of 3.26 and a beta of 0.24. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.13. CME Group Inc. has a one year low of $218.31 and a one year high of $329.16. The firm has a fifty day simple moving average of $267.70 and a two-hundred day simple moving average of $275.31.

CME Group (NASDAQ:CME) last issued its earnings results on Wednesday, July 22nd. The financial services provider reported $2.99 earnings per share for the quarter, topping the consensus estimate of $2.91 by $0.08. CME Group had a return on equity of 15.60% and a net margin of 63.30%.The business had revenue of $1.71 billion during the quarter, compared to analysts’ expectations of $1.68 billion. During the same period in the prior year, the business earned $2.96 EPS. The business’s revenue for the quarter was up .8% compared to the same quarter last year. As a group, equities research analysts expect that CME Group Inc. will post 12.27 earnings per share for the current year.

CME Group Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, September 25th. Shareholders of record on Wednesday, September 9th will be paid a $1.30 dividend. The ex-dividend date is Wednesday, September 9th. This represents a $5.20 dividend on an annualized basis and a yield of 1.9%. CME Group’s dividend payout ratio (DPR) is 44.11%.

Insiders Place Their Bets

In other news, CEO Terrence Duffy sold 15,000 shares of the business’s stock in a transaction dated Thursday, September 10th. The stock was sold at an average price of $274.44, for a total transaction of $4,116,600.00. Following the sale, the chief executive officer owned 40,630 shares in the company, valued at approximately $11,150,497.20. The trade was a 26.96% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director William Shepard acquired 325 shares of the firm’s stock in a transaction that occurred on Thursday, June 25th. The stock was bought at an average cost of $230.57 per share, with a total value of $74,935.25. Following the completion of the transaction, the director directly owned 260,442 shares in the company, valued at $60,050,111.94. The trade was a 0.12% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Corporate insiders own 0.30% of the company’s stock.

CME Group Profile

CME Group Inc operates global derivatives marketplaces that provide trading, clearing and settlement services for a broad range of financial and commodity products. Its exchange platforms enable participants to manage risk, discover prices and gain exposure to asset classes including interest rates, equity indexes, foreign exchange, energy, metals, agricultural commodities and digital assets.

The company’s principal marketplaces include CME, CBOT, NYMEX and COMEX. Products are offered through futures and options contracts, with electronic trading available through CME Globex as well as exchange-based and privately negotiated transactions.